New study rebuts the claim that antidepressants do not work

August 18, 2017, University of Gothenburg
Antidepressant
Fluoxetine (Prozac). Image: Wikimedia Commons

A theory that has gained considerable attention in international media, including Newsweek and the CBS broadcast 60 minutes, suggests that antidepressant drugs such as the SSRIs do not exert any actual antidepressant effect. A research group at the Sahlgrenska Academy has now analyzed data from clinical trials and can rebut this theory.

According to the challenged hypothesis, the fact that many people medicating with antidepressants regard themselves as improved may be attributed to a effect, i.e. that someone who expects to be improved by a medication often also feels improved, even if the medicine lacks actual effect.

However, if SSRIs had, indeed, acted merely by means of a placebo effect, these drugs should not outperform actual placebo in clinical trials where patients have been treated with an SSRI or with ineffective placebo pills, and where neither the physician nor the patient knows which treatment the patient has been given until the study is over.

To explain why antidepressants in such trials nevertheless often cause greater symptom relief than placebo, it has been suggested that SSRI-induced side effects will make the patient understand that he or she has not been given placebo, hence enhancing his or her belief of having been given an effective treatment.

The beneficial effect of SSRIs that has been shown in many studies should thus, according to this theory, not be due to the fact that these drugs exert a specific biochemical antidepressant action in the brain, but that the side effects of the drugs enhance a psychological .

This theory has been widely disseminated despite the fact that there has never been any robust scientific support for it. Thus, so far, it has never been investigated whether individuals in clinical trials experiencing side effects from antidepressant medication, and for this reason may have guessed that they have not received placebo, also respond more favorably to treatment than those without side effects.

In order to examine the "placebo breaking the blind" theory, a research group at the Sahlgrenska Academy in Gothenburg, Sweden, has now analyzed data from the clinical trials that were once undertaken to establish the antidepressant efficacy of two of the most commonly used SSRIs, paroxetine and citalopram.

The analysis, which comprised a total of 3 344 patients, shows that the two studied drugs are clearly superior to placebo with respect to antidepressant efficacy also in patients who have not experienced any side effects. The theory that antidepressants outperform placebo merely by means of side effects making the patient aware that they have not received placebo, and enhancing the expectancy of improvement, may hence be rejected.

The researchers conclude that this study, as well as other recent reports from the same group, provides strong support for the assumption that SSRIs exert a specific antidepressant effect. They suggest that the frequent questioning of these drugs in media is unjustified and may make depressed patients refrain from effective treatment.

Explore further: Are antidepressants more effective than usually assumed?

More information: F Hieronymus et al. Efficacy of selective serotonin reuptake inhibitors in the absence of side effects: a mega-analysis of citalopram and paroxetine in adult depression, Molecular Psychiatry (2017). DOI: 10.1038/mp.2017.147

Related Stories

Are antidepressants more effective than usually assumed?

May 27, 2015
Many have recently questioned the efficacy of the most common antidepressant medications, the selective serotonin reuptake inhibitors (SSRIs). The conclusion that these drugs are ineffective is however partly based on a misinterpretation ...

Placebo effective despite intellectual disability

May 17, 2017
Contrary to earlier beliefs, people with severe congenital intellectual disability are sensitive to placebo-like effects, new research from Karolinska Institutet shows, published in the scientific journal Neurology. The results ...

Antidepressant efficacy varies for depressive symptom clusters

February 28, 2017
(HealthDay)—Antidepressant treatment efficacy varies for empirically-defined clusters of symptoms, according to a study published online Feb. 22 in JAMA Psychiatry.

Antidepressants may be no better than a placebo, so why take them?

October 29, 2014
Seventeenth-century Oxford scholar Robert Burton's lifework, The Anatomy of Melancholy, weighs in at a door-stopping 1,400 pages. But his cure for the "Black Choler" of depression came down to just six words: "Be not solitary, ...

Antidepressants boost CBT for social anxiety

July 5, 2016
Treatments for social anxiety disorder often include either selective serotonin reuptake inhibitors (SSRIs) or cognitive behavioural therapy (CBT), but new research from Uppsala University indicates that social anxiety disorder ...

Common antidepressant increased coronary atherosclerosis in animal model

April 6, 2015
A commonly prescribed antidepressant caused up to a six-fold increase in atherosclerosis plaque in the coronary arteries of non-human primates, according to a study by researchers at Wake Forest Baptist Medical Center. Coronary ...

Recommended for you

Linguistic red flags from Facebook posts can predict future depression diagnoses

October 15, 2018
In any given year, depression affects more than 6 percent of the adult population in the United States—some 16 million people—but fewer than half receive the treatment they need. What if an algorithm could scan social ...

Early changes to synapse gene regulation may cause Alzheimer's disease

October 15, 2018
Alzheimer's disease (AD) is the most common form of dementia, involving memory loss and a reduction in cognitive abilities. Patients with AD develop multiple abnormal protein structures in their brains that are thought to ...

Clues that suggest people are lying may be deceptive, study shows

October 12, 2018
The verbal and physical signs of lying are harder to detect than people believe, a study suggests.

Why don't we understand statistics? Fixed mindsets may be to blame

October 12, 2018
Unfavorable methods of teaching statistics in schools and universities may be to blame for people ignoring simple solutions to statistical problems, making them hard to solve. This can have serious consequences when applied ...

From 'problem child' to 'prodigy'? LSD turns 75

October 12, 2018
Lysergic acid diethylamide was labelled a "problem child" by the man who discovered its hallucinogenic properties in 1943: as it turns 75, the drug known as LSD may now be changing its image.

How to avoid raising a materialistic child

October 12, 2018
If you're a parent, you may be concerned that materialism among children has been on the rise. According to research, materialism has been linked to a variety of mental health problems, such as anxiety and depression, as ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.